Richard Newitter

Stock Analyst at Truist Securities

(2.33)
# 924
Out of 5,370 analysts
428
Total ratings
54.55%
Success rate
18.74%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
TNDM Tandem Diabetes Care
Initiates Coverage On: Hold
24
20 20% 1 Jun 16, 2025
DXCM DexCom
Initiates Coverage On: Buy
102
83.28 22.48% 1 Jun 16, 2025
PODD Insulet
Initiates Coverage On: Buy
365
305.89 19.32% 1 Jun 16, 2025
BBNX Beta Bionics
Initiates Coverage On: Buy
26
19.53 33.13% 1 Jun 16, 2025
GMED Globus Medical
Maintains: Hold
80 68
58.89 15.47% 27 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
127 117
77.64 50.7% 18 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
140 137
121.02 13.2% 37 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
390 400
376.8 6.16% 19 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140 135
100.5 34.33% 5 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
140 150
118.44 26.65% 7 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
113 117
101.47 15.31% 12 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
605 590
518.65 13.76% 28 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 70
60.59 15.53% 14 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
61 51
41.62 22.54% 3 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 8
5.74 39.37% 14 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 90
87.94 2.34% 15 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 24
21.17 13.37% 10 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 19
12.4 53.23% 18 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
78 75
74.71 0.39% 18 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
111 145
144.35 0.45% 16 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
250 235
129.39 81.62% 24 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
118 113
92.12 22.67% 32 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
240 285
261.37 9.04% 5 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
7 5
n/a n/a 11 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 63
n/a n/a 15 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
48 51
n/a n/a 7 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 21
17.91 17.25% 1 Jan 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
12 7
n/a n/a 3 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 80
n/a n/a 3 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
30 31
n/a n/a 3 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
14.06 42.25% 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
71 82
86.02 -4.67% 5 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
29
n/a n/a 11 Aug 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
260 250
172.18 45.2% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 110
n/a n/a 5 May 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 26
3.25 700% 4 May 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
690 770
182.34 322.29% 10 Apr 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
94 85
65.16 30.45% 6 Apr 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
12.26 63.13% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 27
9.74 177.21% 5 Feb 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 32
n/a n/a 6 Jun 21, 2018